Game-Based Intervention for Bullying: Assessing the Efficacy of the RE Think Therapeutic Game in Primary School Children.

J Interpers ViolenceMay 26, 2026 (epub)
Clinical ResearchPsychiatryPediatrics

Maria Țolea, Cristina Tomoiagă, Oana A David

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the RE Think therapeutic game’s impact on emotion regulation and bullying behaviors in 75 primary school children. The intervention group showed significant improvements in emotional control and reductions in victimization compared to the control group, with small to medium effect sizes noted. The study highlights the potential of game-based interventions in addressing bullying.

Key findings

  • Children in the intervention group showed significant reductions in victimization from verbal, physical, or social bullying.
  • The RE Think game led to increased emotional control and lower levels of irrationality.
  • Small to medium effect size improvements were observed in the intervention group compared to controls.

Why it matters

Addressing bullying and enhancing emotional regulation in children is crucial for their long-term mental health and social development. Effective interventions can mitigate the negative impacts of bullying, fostering healthier school environments.

Source

PubMed · PMID 42198883

Published in J Interpers Violence. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.